Chemical diversification of polyprenyl quinones for mechanistic studies on menaquinone-binding peptide antibiotics

  • Eilidh J. Matheson
  • , Roy A.M. van Beekveld
  • , Paolo Innocenti
  • , Nathaniel I. Martin
  • , Markus Weingarth
  • , Stephen A. Cochrane*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Downloads (Pure)

Abstract

Polyprenyl quinones, such as ubiquinone and menaquinone, are essential membrane-embedded redox cofactors that are involved in electron transport and found across all domains of life. However, their highly hydrophobic structure, which includes a quinone head-group and long polyprenyl tail, has limited their chemical derivatization for biological studies. Here, we report a versatile synthetic approach for the chemical diversification of natural polyprenyl quinones, enabling the introduction of various reporter groups including fluorophores, quenchers, NMR-active nuclei, and photoaffinity and bioaffinity tags. These functionalized analogues retain their membrane-associating properties and enable new applications in antibiotic discovery. We show that fluorescently labelled menaquinone analogues retain their strong binding affinity to the menaquinone-binding peptide antibiotics lysocin E and lysomeb (MBA2). Incorporation of BODIPY-quinones into vesicles allowed visualization of the peptide-quinone interaction, revealing their effects on membrane integrity and quinone aggregation. This study expands the chemical toolbox for polyprenyl quinones, enabling targeted functionalization of these essential biomolecules and facilitating further exploration of their roles in biological systems.

Original languageEnglish
Pages (from-to)13629-13635
Number of pages7
JournalChemical Science
Volume16
Issue number30
Early online date03 Jul 2025
DOIs
Publication statusPublished - 30 Jul 2025

ASJC Scopus subject areas

  • General Chemistry

Fingerprint

Dive into the research topics of 'Chemical diversification of polyprenyl quinones for mechanistic studies on menaquinone-binding peptide antibiotics'. Together they form a unique fingerprint.

Cite this